GB0020588D0 - Treatment of wounds - Google Patents

Treatment of wounds

Info

Publication number
GB0020588D0
GB0020588D0 GBGB0020588.0A GB0020588A GB0020588D0 GB 0020588 D0 GB0020588 D0 GB 0020588D0 GB 0020588 A GB0020588 A GB 0020588A GB 0020588 D0 GB0020588 D0 GB 0020588D0
Authority
GB
United Kingdom
Prior art keywords
wounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0020588.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB0020588.0A priority Critical patent/GB0020588D0/en
Publication of GB0020588D0 publication Critical patent/GB0020588D0/en
Priority to US09/927,344 priority patent/US20020065286A1/en
Priority to PCT/IB2001/001470 priority patent/WO2002015893A2/en
Priority to CA002415791A priority patent/CA2415791A1/en
Priority to IL15401101A priority patent/IL154011A0/en
Priority to KR10-2003-7002520A priority patent/KR20030097778A/en
Priority to JP2002520814A priority patent/JP2004519425A/en
Priority to EP01954296A priority patent/EP1311252A2/en
Priority to HU0303029A priority patent/HUP0303029A3/en
Priority to AU2001276636A priority patent/AU2001276636A1/en
Priority to ZA200301156A priority patent/ZA200301156B/en
Priority to US10/928,028 priority patent/US20050148585A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
GBGB0020588.0A 2000-08-21 2000-08-21 Treatment of wounds Ceased GB0020588D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB0020588.0A GB0020588D0 (en) 2000-08-21 2000-08-21 Treatment of wounds
US09/927,344 US20020065286A1 (en) 2000-08-21 2001-08-10 Treatment of wounds
AU2001276636A AU2001276636A1 (en) 2000-08-21 2001-08-16 Treatment of wounds
IL15401101A IL154011A0 (en) 2000-08-21 2001-08-16 Treatment of wounds
CA002415791A CA2415791A1 (en) 2000-08-21 2001-08-16 Treatment of wounds
PCT/IB2001/001470 WO2002015893A2 (en) 2000-08-21 2001-08-16 Treatment of wounds
KR10-2003-7002520A KR20030097778A (en) 2000-08-21 2001-08-16 Treatment of wounds
JP2002520814A JP2004519425A (en) 2000-08-21 2001-08-16 Wound healing
EP01954296A EP1311252A2 (en) 2000-08-21 2001-08-16 Treatment of wounds
HU0303029A HUP0303029A3 (en) 2000-08-21 2001-08-16 Use of pharmaceutical compositions containing cgmp-5pde inhibitors for treatment of wounds
ZA200301156A ZA200301156B (en) 2000-08-21 2003-02-12 Treatment of wounds.
US10/928,028 US20050148585A1 (en) 2000-08-21 2004-08-26 Treatment of wounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0020588.0A GB0020588D0 (en) 2000-08-21 2000-08-21 Treatment of wounds

Publications (1)

Publication Number Publication Date
GB0020588D0 true GB0020588D0 (en) 2000-10-11

Family

ID=9898022

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0020588.0A Ceased GB0020588D0 (en) 2000-08-21 2000-08-21 Treatment of wounds

Country Status (10)

Country Link
EP (1) EP1311252A2 (en)
JP (1) JP2004519425A (en)
KR (1) KR20030097778A (en)
AU (1) AU2001276636A1 (en)
CA (1) CA2415791A1 (en)
GB (1) GB0020588D0 (en)
HU (1) HUP0303029A3 (en)
IL (1) IL154011A0 (en)
WO (1) WO2002015893A2 (en)
ZA (1) ZA200301156B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133903B2 (en) 2003-10-21 2012-03-13 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
TWI339578B (en) 2004-10-29 2011-04-01 Mitsubishi Tanabe Pharma Corp Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
GB2459098A (en) * 2008-04-08 2009-10-14 Ethicon Inc Genetic markers of wound development
WO2010062366A1 (en) * 2008-10-31 2010-06-03 Arginetix, Inc. Compositions and methods of treating endothelial disorders
JP2013523809A (en) * 2010-04-05 2013-06-17 エスケー ケミカルズ カンパニー リミテッド Composition for improving skin wrinkle containing PDE5 inhibitor
AT512084A1 (en) 2011-10-20 2013-05-15 Univ Wien Tech DIAZABICYCLO AND DIAZASPIRO ALKAN DERIVATIVES AS PHOSPHODIESTERASE-5 INHIBITORS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2333041A (en) * 1998-01-13 1999-07-14 Johnson & Johnson Medical Ltd Wound Composition
AU1025899A (en) * 1998-09-16 2000-04-03 Icos Corporation Carboline derivatives as cgmp phosphodiesterase inhibitors
CZ20012113A3 (en) * 1998-12-14 2001-11-14 Cellegy Pharmaceuticals, Inc. Preparations and methods for treating anorectal area
GB0000561D0 (en) * 2000-01-11 2000-03-01 Pfizer Ltd Treatment of diabetic ulcers
CA2406947A1 (en) * 2000-04-19 2001-10-25 Johns Hopkins University Methods for prevention and treatment of gastrointestinal disorders
AU2001268064A1 (en) * 2000-06-07 2001-12-17 Lilly Icos Llc Derivatives of 2,3,6,7,12,12a-hexahydropyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
CN1440287A (en) * 2000-06-30 2003-09-03 辉瑞大药厂 Method of treating peripheral vascular diseases, peripheral neuropathies, and automatic neuropathies
IL154202A0 (en) * 2000-07-31 2003-07-31 Cellegy Pharma Inc Pharmaceutical compositions for treating anorectal disorders

Also Published As

Publication number Publication date
AU2001276636A1 (en) 2002-03-04
HUP0303029A3 (en) 2004-11-29
JP2004519425A (en) 2004-07-02
CA2415791A1 (en) 2002-02-28
KR20030097778A (en) 2003-12-31
IL154011A0 (en) 2003-07-31
HUP0303029A2 (en) 2003-12-29
EP1311252A2 (en) 2003-05-21
WO2002015893A3 (en) 2003-03-13
WO2002015893A2 (en) 2002-02-28
ZA200301156B (en) 2004-04-16

Similar Documents

Publication Publication Date Title
AU2002342613A8 (en) Treatment for wounds
EP1267798A4 (en) Treatment of skin damage using polyenylphosphatidylcholine
GB0015745D0 (en) Treatment of bone diseases
AU7863201A (en) Treatment of hyperproliferative diseases
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU5464601A (en) Treatment of scale
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
AU5000001A (en) Treatment of vitiligo
GB0001710D0 (en) Therapeutic treatment
HRP20020729A2 (en) Treatment of psoriasis
NZ513686A (en) Treatment of trauma
GB2360453B (en) Treatment of skin conditions
GB0020588D0 (en) Treatment of wounds
AU2096002A (en) Therapeutic treatment
GB0114231D0 (en) Treatment of multiple sclerosis
GB2381455B (en) Treatment of burns
EP1303281A4 (en) Methods of treatment
GB0031321D0 (en) Treatment
GB0013928D0 (en) Methods of treatment
GB0014904D0 (en) Methods of treatment
AUPR008500A0 (en) Treatment of pathogens
EP1284748A4 (en) Treatment of damaged connective tissue
AU2638002A (en) Tissue treatment
AU6191201A (en) Treatment of effluent

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)